Purpose: Cancer remains a significant cause of morbidity and mortality across the globe. A
recent report suggests around 14.1 million new cases and 8.2 million cancer-related deaths …

Highlights•A systematic review on how new-generation nanomedicine enables the
navigation of nanocarriers in a tumor.•Hybrid nanoplatforms improving chemotherapeutic …

The implementation of cytotoxic chemotherapeutic drugs in the fight against cancer has
played an invariably essential role for minimizing the extent of tumour progression and/or …

The use of nanotechnology has the potential to revolutionize the detection and treatment of
cancer. Developments in protein engineering and materials science have led to the …

Chemotherapeutic agents have limited efficacy and resistance to them limits today and will
limit tomorrow our capabilities of cure. Resistance to treatment with anticancer drugs results …

For the last one decade, scientists are working at developing nano anti-cancer drugs with
the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many …

The emerging field of nanotechnology meets the demands for innovative approaches in the
diagnosis and treatment of cancer. The nanoparticles are biocompatible and biodegradable …

Introduction: Resistance to chemotherapy is a major obstacle in the successful amelioration
of tumors in many cancer patients. Resistance is either intrinsic or acquired, involving …

Multidrug resistance (MDR) is a major impediment to the success of cancer chemotherapy. P-
glycoprotein is an important and the best-known membrane transporter involved in MDR …

As one of the most important cancer treatment strategies, conventional chemotherapy has
substantial side effects and leads easily to cancer treatment failure. Therefore, exploring and …